Chemotherapy: Pemetrexed Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

Jemincare1
Janssen Research & Development, LLC1

Indications

Lung Cancer2
Cancer2
NSCLC (Advanced Non-small Cell Lung Cancer)1
Carcinoma, Non-Small-Cell Lung1

Other1 trial

A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation

Phase 1

Daphne, Alabama1 trial

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Southern Cancer Center, PC

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.